DUBLIN, May 20, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Cardiac Medical Devices Market in the US 2016-2020" report to their offering.
The cardiac medical devices market in the US is expected to grow at a CAGR of 1.82% during the period 2016-2020.
The market is divided into the following segments based on product type:
- Cardiac rhythm management (CRM) devices
- Cardiac assist devices
- Heart valve
Vendors are increasingly involving in mergers and acquisitions as a business strategy to expand their operation and market share. Acquisitions of small companies by large vendors help large players increase their product portfolio.
According to the report, the market is growing due to the increased sales of cardiac rhythm management (CRM) devices. Increasing incidence and prevalence of cardiac disorders such as bradycardia, ventricular fibrillation, and tachycardia can lead to sudden cardiac arrest. To treat these patients, CRM devices are implanted that can boost the growth of the market.
Further, the report states that high cost associated with cardiac devices is hindering the growth of the market.
Key vendors:
- Boston Scientific
- LivaNova
- Medtronic
- St. Jude Medical
Key Topics Covered:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Regulation and reimbursement scenario in US
PART 06: Market landscape
PART 07: Market segmentation by product type
PART 08: Market drivers
PART 09: Impact of drivers
PART 10: Market challenges
PART 11: Impact of drivers and challenges
PART 12: Market trends
PART 13: Vendor landscape
For more information visit http://www.researchandmarkets.com/research/h6lptd/cardiac_medical
Media Contact:
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Share this article